Skip to main content

John Robertson, MD, BSc, FRCS

John Robertson, MD chB BSc, MD, FRCS
Conference Coverage
12/08/2023
John Robertson MB chB BSc, MD, FRCS, shared results from the SERENA-3 trial, investigating the effect multiple doses of camizestrant at different treatment durations has on ER, ki-67, and PgR expression.
John Robertson MB chB BSc, MD, FRCS, shared results from the SERENA-3 trial, investigating the effect multiple doses of camizestrant at different treatment durations has on ER, ki-67, and PgR expression.
John Robertson MB chB BSc, MD,...
12/08/2023
Oncology